Cargando…

An anti-cancer Smurf

A novel, cancer-fighting function was recently discovered for Smad ubiquitination regulatory factor 2 (Smurf2).

Detalles Bibliográficos
Autores principales:	Zhao, Keji, Shi, Yun-Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342207/ https://www.ncbi.nlm.nih.gov/pubmed/22429979 http://dx.doi.org/10.1186/2045-3701-2-10

Ejemplares similares

An integrated strategy for identification of both sharp and broad peaks from next-generation sequencing data
por: Peng, Weiqun, et al.
Publicado: (2011)

Smurfs in Protein Homeostasis, Signaling, and Cancer
por: Koganti, Praveen, et al.
Publicado: (2018)

Skeletal Characterization of Smurf2-Deficient Mice and In Vitro Analysis of Smurf2-Deficient Chondrocytes
por: Huang, Henry, et al.
Publicado: (2016)

Smurf1 and Smurf2 mediated polyubiquitination and degradation of RNF220 suppresses Shh-group medulloblastoma
por: Li, Yuwei, et al.
Publicado: (2023)

Modulating serine palmitoyltransferase‐deoxysphingolipid axis in cancer therapy
por: Xiang, Yuancai, et al.
Publicado: (2020)

A good sugar, d-mannose, suppresses autoimmune diabetes
por: Shi, Yun-Bo, et al.
Publicado: (2017)

Evolutionary insights into postembryonic development of adult intestinal stem cells
por: Ishizuya-Oka, Atsuko, et al.
Publicado: (2011)

iPSCs are safe!
por: Yan, Hualong, et al.
Publicado: (2017)

Posttranslational Modifications of Smurfs: Emerging Regulation in Cancer
por: Yang, Longtao, et al.
Publicado: (2021)

Targeting programmed death ligand 2/repulsive guidance molecule b pathway: a novel strategy to subdue tumor immunotherapy resistance to anti‐programmed death 1/programmed death ligand 1
por: Xiang, Yuancai, et al.
Publicado: (2023)

SMURF1 Amplification Promotes Invasiveness in Pancreatic Cancer
por: Kwei, Kevin A., et al.
Publicado: (2011)

SMURF1 and SMURF2 in Progenitor Cells from Articular Cartilage and Meniscus during Late-Stage Osteoarthritis
por: Schminke, Boris, et al.
Publicado: (2020)

Tumor‐derived microparticles in tumor immunology and immunotherapy
por: Ma, Jingwei, et al.
Publicado: (2020)

The dual role of ROS, antioxidants and autophagy in cancer
por: Walton, Emma Louise
Publicado: (2016)

Importance of producing economic compounds to combat cancer
por: Muñoz‐Rojas, Jesús
Publicado: (2017)

High hopes and high honours for cancer immunotherapy
por: Häfner, Sophia Julia
Publicado: (2019)

Targeting FMRP: A new window for cancer immunotherapy
por: Zhang, Yaguang, et al.
Publicado: (2023)

循环肿瘤细胞捕获材料的研究进展
por: SUN, Wenjing, et al.
Publicado: (2021)

Regulatory T cell metabolism at the intersection between autoimmune diseases and cancer
por: Kurniawan, Henry, et al.
Publicado: (2020)

Innate lymphoid cells and cancer: Role in tumor progression and inhibition
por: Yuan, Xiaodong, et al.
Publicado: (2021)

Directed evolution, natural products for cancer chemotherapy, and micro‐biosensing robots
por: Daniels, Craig, et al.
Publicado: (2011)

Two sides of the same coin: tyrosine kinase inhibition in cancer and neurodegeneration
por: Hebron, Michaeline, et al.
Publicado: (2015)

Can cannibalizing cancer cells challenge classic cell death classification?
por: Walton, Emma Louise
Publicado: (2017)

Tumour travel tours – Why circulating cancer cells value company
por: Häfner, Sophia Julia
Publicado: (2020)

Functional and metabolic dichotomy of murine γδ T cell subsets in cancer immunity
por: Lopes, Noëlla, et al.
Publicado: (2020)

A tug-of-war to control plant emission of an airborne alarm signal
por: Hao, Jie, et al.
Publicado: (2023)

AIDing cancer treatment: Reducing AID activity via HSP90 inhibition
por: Rebhandl, Stefan, et al.
Publicado: (2015)

Linking metabolic and epigenetic regulation in the development of lung cancer driven by TGFβ signaling
por: Zhang, Liyi
Publicado: (2019)

Struggling to get a universal meningococcal vaccine and novel uses for bacterial toxins in cancer treatment
por: Daniels, Craig, et al.
Publicado: (2010)

Mechanism of action of PD‐1 receptor/ligand targeted cancer immunotherapy [Image: see text]
por: Borst, Jannie, et al.
Publicado: (2021)

Enzalutamide: the emperor of all anti-androgens
por: Antonarakis, Emmanuel S.
Publicado: (2013)

Raising the Awareness of Undergraduate Nurses to the Psychosocial Impact of Living with Cancer: A Consumer Engagement in Teaching Initiative
por: Zannettino, Lana, et al.
Publicado: (2016)

Constant regulation for stable CD8 T‐cell functional avidity and its possible implications for cancer immunotherapy
por: Gilfillan, Connie B., et al.
Publicado: (2021)

Margetuximab: An active alternative for later‐line therapy in patients with HER2‐positive advanced breast cancer
por: Zhou, Yunxiang, et al.
Publicado: (2023)

Circadian‐rhythm‐regulating hormones: Key factors to regulate breast cancer metastasis via circulating tumor cells
por: Liu, Chenguang, et al.
Publicado: (2022)

Ramucirumab, another anti-angiogenic agent for metastatic colorectal cancer in second-line setting—its impact on clinical practice
por: Goel, Gaurav, et al.
Publicado: (2015)

A new mission for an old anti-cancer drug: harnessing hepatocyte-specific metabolic pathways against liver tumors
por: Liao, Weiting, et al.
Publicado: (2023)

Development and characterisation of SMURF2-targeting modifiers
por: Manikoth Ayyathan, Dhanoop, et al.
Publicado: (2021)

Unveiling new anti-inflammatory mechanisms of nanomaterials
por: Gu, Zhen
Publicado: (2023)

Generation of Smurf2 Conditional Knockout Mice
por: Tang, Yi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_elul3iu2qpbl0r5damaat65lq3